Omalizumab for chronic spontaneous urticaria in real-life practice

被引：0
|
作者：
Cubiro, Xavier [1 ]
Spertino, Jorge [1 ]
Puig, Lluis [1 ]
Serra-Baldrich, Esther [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2018年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6868
引用
收藏
页码：AB209 / AB209
页数：1
相关论文
共 50 条
  • [21] Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation
    Bras, Rita
    Costa, Celia
    Limao, Rita
    Caldeira, Leonor Esteves
    Paulino, Marisa
    Pedro, Elisa
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (08): : 2392 - 2402
  • [22] Omalizumab treatment in patients with severe chronic spontaneous urticaria: consideration from real-life experience in Italy
    Asero, Riccardo
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 : 1 - 2
  • [23] Real-life treatment of cholinergic urticaria with omalizumab
    Altrichter, Sabine
    Chuamanochan, Mati
    Knoth, Henriette
    Asady, Aida
    Ohanyan, Tatevik
    Metz, Martin
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : 788 - +
  • [24] Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
    Calzari, Paolo
    Chiei Gallo, Alessandra
    Barei, Francesca
    Bono, Eleonora
    Cugno, Massimo
    Marzano, Angelo Valerio
    Ferrucci, Silvia Mariel
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [25] Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data
    Salman, Andac
    Aktas, Meryem
    Sengun, Ozlem Apti
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 (03) : 398 - 402
  • [26] Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study
    Salman, Andac
    Ergun, Tulin
    Maria Gimenez-Arnau, Ana
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (02) : 204 - 209
  • [27] Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes
    Dursun, A. B.
    Karakis, Pasaoglu G.
    Ayhan, V
    ALLERGY, 2016, 71 : 187 - 187
  • [28] Real-Life Experiences With Omalizumab For The Treatment Of Severe Refractory Chronic Urticaria (SRCIU)
    Barron, Carly
    Sussman, Gordon L.
    Hebert, Jacques
    Bian, Jiayi
    Caron-Guay, Rose-Marie
    Laflamme, Stephanie
    Stern, Simon
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB118 - AB118
  • [29] Omalizumab in chronic urticaria; real-life data of 6-year-experience
    Ozdemir, Adem
    Bilgic, Asli
    Koyuncu, Mehmet Ali
    Yilmaz, Ertan
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2021, 15 (03): : 66 - 73
  • [30] Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice
    Bongiorno, Maria Rita
    Crimi, Nunzio
    Corrao, Salvatore
    Allotta, Alberto
    Arena, Antonino
    Brusca, Ignazio
    Heffler, Enrico
    Malara, Giovanna
    Milioto, Mirella
    Pistone, Giuseppe
    Porto, Morena
    Raia, Emilio
    Valenti, Giuseppe
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (06) : 703 - 707
12345